Status
Conditions
Treatments
About
An open-label,pilot study to evaluate the efficacy and safety of plasma exchange combination of immunosuppressive regimens, for the remission of autoimmune hepatitis (AIH).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
The presence of hepatitis A, B, C, D, or E virus infection;
Primary purpose
Allocation
Interventional model
Masking
20 participants in 1 patient group
Loading...
Central trial contact
Xiaoli Fan, MM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal